The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 21, 2023

Filed:

Apr. 24, 2017
Applicant:

Obi Pharma, Inc., Taipei, TW;

Inventors:

Cheng-Der Tony Yu, Taipei, TW;

Youe-Kong Shue, Taipei, TW;

Chen-Hsin Liang, Taipei, TW;

Peiwen Yu, Taipei, TW;

Chwen-Cheng Chen, Taipei, TW;

Assignee:

OBI PHARMA, INC., Taipei, TW;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); A61K 39/00 (2006.01); A61P 35/00 (2006.01); G01N 33/574 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 39/001173 (2018.08); A61K 39/00118 (2018.08); A61P 35/00 (2018.01); G01N 33/57407 (2013.01); G01N 33/57415 (2013.01); G01N 33/57492 (2013.01); A61K 45/06 (2013.01); A61K 2039/545 (2013.01); A61K 2039/55577 (2013.01); A61K 2039/575 (2013.01); A61K 2039/6081 (2013.01); G01N 2400/38 (2013.01); G01N 2800/52 (2013.01);
Abstract

The disclosure provides a method of immunotherapy for a cancer patient, comprises administering vaccines against Globo series antigens (i.e., Globo H, Stage-specific embryonic antigen 3 'SSEA3' and Stage-specific embryonic antigen 4 'SSEA4'). Specifically, the method comprises administering Globo H-KLH (OBI-822) in patients with Metastatic Breast Cancer. The disclosure also provides a method of comprises selecting a cancer patient who is suitable as treatment candidate for immunotherapy. In addition, the disclosure provides therapeutic agents, including monoclonal antibodies (mAbs) that bind specifically to Globo series antigens and related biomarkers useful in focusing such therapeutic and diagnostic regimens.


Find Patent Forward Citations

Loading…